TRAW

NASDAQ · Pharmaceuticals

Traws Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.22

+0.00 (+0.82%)

As of Nov 7, 2:46 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +9,922.5% upside

Low Target $15.33

Average Target $22.24

High Target $34.90

Current Price $0.22

Current
$0.22

Target
$22.24

$15.33 $22.24 avg $34.90

Scenario Analysis

Bear Case

$15.33

6,808.5%

Low target

Base Case

$22.24

+9,922.5%

Avg target

Bull Case

$34.90

+15,627.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$3.23

-93.1% from high

52-Week Low

$0.22

+1.5% from low

Target vs 52W High

$22.24

+588.5% vs high

Next Earnings Report

Nov 11, 2026

until earnings

EPS Est: $-0.21

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+164.3%